Record Growth Anticipated for Scottish Biotech
Another multi million pound contract boosts Scotland's booming biotech industry and confirms Japan's appetite for Scottish scientific research. A recent £4.5 million deal between Glasgow-based Scottish Biomedical and Japanese drugs giant Kyorin is the latest in a string of successful collaborations between innovative Scottish science and Japanese industry.…
This is one of many successes applauded by Scotland's Deputy First Minister, Jim Wallace, on a visit to the Far East, where he announced that Scotland's biotechnology industry is growing at twice the pace of its European counterparts.
Speaking at a meeting with Fujisawa Pharmaceuticals and Mitsubishi Pharma, both of whom have joint research projects with Scottish universities, Mr Wallace said: "Scotland's biotechnology sector is growing at almost twice the pace of the industry in the rest of Europe - 28% compared to 15% elsewhere."
The latest figures, published on February 12th 2004 in a Scottish Enterprise Report, show the trend continuing, with growth at more than 20% in each of the last 2 years. Scotland's biotech industry now has over 515 organisations employing more than 26,500 people and with Edinburgh picked as the destination for the BioEquity Europe Conference in May 2004, Scotland looks set to strengthen its position at the heart of global biotechnology.